Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome

Journal of Psychosomatic Research

Volumn 56, Issue 4, 2004, Pages 419-424

  Gaab, Jens ^a,b   Engert, Veronika ^a   Heitz, Vera ^a   Schad, Tanja ^a   Schürmeyer, Thomas H ^a   Ehlert, Ulrike ^a,c  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Institute for Psychology   (Germany)

Author keywords

ACTH, CRH, Symptoms; Anxiety; Chronic Fatigue Syndrome; Cortisol; Depression; Duration; HPA axis; Inactivity

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN TOLERANCE TEST; MALE; NEUROENDOCRINOLOGY; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 1842828885     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(03)00625-1     Document Type: Article

References (50)

1. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1121:1994;953-959.
2. Demitrack M.A., Greden J.F. Chronic fatigue syndrome: the need for an integrative approach. Biol Psychiatry. 30:1991;747-752.
3. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med. 105:1998;35S-42S.
4. Patarca-Montero R., Antoni M., Fletcher M.A., Klimas N.G. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol. 8:2001;51-64.
5. Cleare A.J., Wessely S.C. Chronic fatigue syndrome: a stress disorder? Br J Hosp Med. 55:1996;571-574.
6. Parker A.J., Wessely S., Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med. 31:2001;1331-1345.
7. Ehlert U., Gaab J., Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 57:2001;141-152.
8. Demitrack M.A. The psychobiology of Chronic Fatigue Syndrome: the central nervous system as a common pathway. Demitrack M.A., Abbey S.E. Chronic Fatigue Syndrome: an integrative approach to evaluation and treatment. 1997;72-112 The Guildford Press, New York.
9. Wessely S., Chalder T., Hirsch S., Pawlikowska T., Wallace P., Wright D.J. Postinfectious fatigue: prospective cohort study in primary care. Lancet. 345:1995;1333-1338.
10. Theorell T., Blomkvist V., Lindh G., Evengard B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med. 61:1999;304-310.
11. Surawy C., Hackmann A., Hawton K., Sharpe M. Chronic fatigue syndrome: a cognitive approach. Behav Res Ther. 33:1995;535-544.
12. Joyce J., Hotopf M., Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med. 90:1997;223-233.
13. Deale A., Chalder T., Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res. 45:1998;77-83.
14. Morriss R.K., Wearden A.J., Battersby L. The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome. J Psychosom Res. 42:1997;597-605.
15. Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 73:1991;1224-1234.
16. Sharpe M.C., Archard L.C., Banatvala J.E., Borysiewicz L.K., Clare A.W., David A., Edwards R.H., Hawton K.E., Lambert H.P., Lane RJet al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med. 84:1991;118-121.
17. Wittchen H-U, Pfister H. DIA-X-Interviews. 1997;Swets and Zeitlinger, Frankfurt.
18. Gaab J., Huster D., Peisen R., Engert V., Schad T., Schurmeyer T.H., Ehlert U. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med. 64:2002;311-318.
19. Gaab J, Hüster D, Peisen R, Engert V, Heitz V, Schad T, Schürmeyer T, Ehlert U. Hypothamalus-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiologial and pharmacological stimuation. Psychosom Med. In press.
20. Fish H.R., Chernow B., O'Brian J.T. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism. 35:1986;763-780.
21. Dressendorfer R.A., Kirschbaum C., Rohde W., Stahl F., Strasburger C.J. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol. 43:1992;683-692.
22. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., Wallace E.P. Development of a fatigue scale. J Psychosom Res. 37:1993;147-153.
23. Kessler S., Jaeckel W., Cziske R. Assessing health in musculoskeletal disorders - the appropriateness of a German version of the Sickness Impact Profile. Rheumatol Int. 17:1997;119-125.
24. Herrmann C., Buss U., Snaith R.P. HADS-D Hospital Anxiety and Depression Scale - Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. 1995;Hans Huber.
25. Franke G. Die Symptom-Checkliste von Derogatis - Deutsche Version. 1995;Beltz Test, Göttingen.
26. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 25:2000;1-35.
27. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 353:1999;455-458.
28. Chalder T., Power M.J., Wessely S. Chronic fatigue in the community: 'a question of attribution'. Psychol Med. 26:1996;791-800.
29. Powell R., Dolan R., Wessely S. Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res. 34:1990;665-673.
30. Clauw D.J., Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 4:1997;134-153.
31. Lariviere W.R., Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain. 84:2000;1-12.
32. Geracioti T.D. Jr., Loosen P.T., Orth D.N. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry. 42:1997;165-174.
33. Magiakou M.A., Mastorakos G., Rabin D., Dubbert B., Gold P.W., Chrousos G.P. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab. 81:1996;1912-1917.
34. Cleare A.J., Blair D., Chambers S., Wessely S. Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry. 158:2001;641-643.
35. Vedhara K., Hyde J., Gilchrist I.D., Tytherleigh M., Plummer S. Acute stress, memory, attention and cortisol. Psychoneuroendocrinology. 25:2000;535-549.
36. Leese G., Chattington P., Fraser W., Vora J., Edwards R., Williams G. Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab. 81:1996;1867-1870.
37. Moldofsky H., Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med. 38:1976;35-44.
38. Morriss R., Sharpe M., Sharpley A.L., Cowen P.J., Hawton K., Morris J. Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ. 306:1993;1161-1164.
39. Buchwald D., Pascualy R., Bombardier C., Kith P. Sleep disorders in patients with chronic fatigue. Clin Infect Dis. 18(Suppl 1):1994;S68-S72.
40. White P.D. The role of physical inactivity in the chronic fatigue syndrome. J Psychosom Res. 49:2000;283-284.
41. Ware N.C. Society, mind and body in chronic fatigue syndrome: an anthropological view. Ciba Found Symp. 173:1993;62-73.
42. Vercoulen J.H., Bazelmans E., Swanink C.M., Fennis J.F., Galama J.M., Jongen P.J., Hommes O., Van Der Meer J.W., Bleijenberg G. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res. 31:1997;661-673.
43. Haines R.F. Effect of bed rest and exercise on body balance. J Appl Physiol. 36:1974;323-327.
44. Greenleaf J.E., Kozlowski S. Physiological consequences of reduced physical activity during bed rest. Exerc Sport Sci Rev. 10:1982;84-119.
45. Natelson B.H., DeRoshia C., Levin B.E. Physiological effects of bed rest. letter Lancet. 1:1982;51.
46. Fulcher K.Y., White P.D. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 314:1997;1647-1652.
47. Luger A., Deuster P.A., Kyle S.B., Gallucci W.T., Montgomery L.C., Gold P.W., Loriaux D.L., Chrousos G.P. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med. 316:1987;1309-1315.
48. Heuser I.J., Wark H.J., Keul J., Holsboer F. Hypothalamic-pituitary- adrenal axis function in elderly endurance athletes. J Clin Endocrinol Metab. 73:1991;485-488.
49. Duclos M., Corcuff J.B., Rashedi M., Fougere V., Manier G. Trained versus untrained men: different immediate post-exercise responses of pituitary adrenal axis. A preliminary study. Eur J Appl Physiol Occup Physiol. 75:1997;343-350.
50. Barron J.L., Noakes T.D., Levy W., Smith C., Millar R.P. Hypothalamic dysfunction in overtrained athletes. J Clin Endocrinol Metab. 60:1985;803-806.